Trichosanthin alleviates streptozotocin-induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow-derived IL6+ and IL10+ MDSCs
Myeloid-derived suppressor cells (MDSCs) occupy a pivotal role in the intricate pathogenesis of the autoimmune disorder, Type 1 diabetes mellitus (T1DM). Since our previous work demonstrated that trichosanthin (TCS), an active compound of Chinese herb medicine Tian Hua Fen, regulated immune response...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023101150 |
_version_ | 1797337099263803392 |
---|---|
author | Jie Shu Kefan Wang Yuting Liu Jie Zhang Xuping Ding Hanxiao Sun Jiaoxiang Wu Biao Huang Ju Qiu Huiming Sheng Liming Lu |
author_facet | Jie Shu Kefan Wang Yuting Liu Jie Zhang Xuping Ding Hanxiao Sun Jiaoxiang Wu Biao Huang Ju Qiu Huiming Sheng Liming Lu |
author_sort | Jie Shu |
collection | DOAJ |
description | Myeloid-derived suppressor cells (MDSCs) occupy a pivotal role in the intricate pathogenesis of the autoimmune disorder, Type 1 diabetes mellitus (T1DM). Since our previous work demonstrated that trichosanthin (TCS), an active compound of Chinese herb medicine Tian Hua Fen, regulated immune response, we aimed to clarify the efficacy and molecular mechanism of TCS in the treatment of T1DM. To this end, T1DM mouse model was established by streptozotocin (STZ) induction. The mice were randomly divided into normal control group (Ctl), T1DM group (STZ), TCS treated diabetic group (STZ + TCS) and insulin-treated diabetic group (STZ + insulin). Our comprehensive evaluation encompassed variables such as blood glucose, glycosylated hemoglobin, body weight, pertinent biochemical markers, pancreatic histopathology, and the distribution of immune cell populations. Furthermore, we meticulously isolated MDSCs from the bone marrow of T1DM mice, probing into the expressions of genes pertaining to the advanced glycation end product receptor (RAGE)/NF-κB signaling pathway through RT-qPCR. Evidently, TCS exhibited a substantial capacity to effectively counteract the T1DM-induced elevation in random blood glucose, glycosylated hemoglobin, and IL-6 levels in plasma. Pathological scrutiny underscored the ability of TCS to mitigate the damage incurred by islets. Intriguingly, TCS interventions engendered a reduction in the proportion of MDSCs within the bone marrow, particularly within the IL-6+ MDSC subset. In contrast, IL-10+ MDSCs exhibited an elevation following TCS treatment. Moreover, we observed a significant down-regulation of relative mRNA of pro-inflammatory genes, including arginase 1 (Arg1), inducible nitric oxide synthase (iNOS), RAGE and NF-κB, within MDSCs due to the influence of TCS. It decreases total MDSCs and regulates the balance between IL-6+ and IL-10+ MDSCs thus alleviating the symptoms of T1DM. TCS also down-regulates the RAGE/NF-κB signaling pathway, making it a promising alternative therapeutic treatment for T1DM. Collectively, our study offered novel insights into the underlying mechanism by which TCS serves as a promising therapeutic intervention for T1DM. |
first_indexed | 2024-03-08T09:04:31Z |
format | Article |
id | doaj.art-7b6f7b65c11e4dbbaae00efc7364d981 |
institution | Directory Open Access Journal |
issn | 2405-8440 |
language | English |
last_indexed | 2024-03-08T09:04:31Z |
publishDate | 2024-01-01 |
publisher | Elsevier |
record_format | Article |
series | Heliyon |
spelling | doaj.art-7b6f7b65c11e4dbbaae00efc7364d9812024-02-01T06:30:22ZengElsevierHeliyon2405-84402024-01-01101e22907Trichosanthin alleviates streptozotocin-induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow-derived IL6+ and IL10+ MDSCsJie Shu0Kefan Wang1Yuting Liu2Jie Zhang3Xuping Ding4Hanxiao Sun5Jiaoxiang Wu6Biao Huang7Ju Qiu8Huiming Sheng9Liming Lu10Department of Clinical Laboratory, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xian Xia Road, Shanghai, 200336, China; Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, 280 Chong Qing South Road, 200025, ChinaShanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, 280 Chong Qing South Road, 200025, ChinaShanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, 280 Chong Qing South Road, 200025, ChinaShanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, 280 Chong Qing South Road, 200025, ChinaShanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, 280 Chong Qing South Road, 200025, ChinaDepartment of Clinical Laboratory, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xian Xia Road, Shanghai, 200336, ChinaDepartment of Clinical Laboratory, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xian Xia Road, Shanghai, 200336, ChinaCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, ChinaThe Key Laboratory of Stem Cell Biology, Shanghai Institutes of Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, ChinaDepartment of Clinical Laboratory, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xian Xia Road, Shanghai, 200336, China; Corresponding author.Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, 280 Chong Qing South Road, 200025, China; Corresponding author. Shanghai Institute of Immunology, 280 Chong Qing South Road, 200025, China.Myeloid-derived suppressor cells (MDSCs) occupy a pivotal role in the intricate pathogenesis of the autoimmune disorder, Type 1 diabetes mellitus (T1DM). Since our previous work demonstrated that trichosanthin (TCS), an active compound of Chinese herb medicine Tian Hua Fen, regulated immune response, we aimed to clarify the efficacy and molecular mechanism of TCS in the treatment of T1DM. To this end, T1DM mouse model was established by streptozotocin (STZ) induction. The mice were randomly divided into normal control group (Ctl), T1DM group (STZ), TCS treated diabetic group (STZ + TCS) and insulin-treated diabetic group (STZ + insulin). Our comprehensive evaluation encompassed variables such as blood glucose, glycosylated hemoglobin, body weight, pertinent biochemical markers, pancreatic histopathology, and the distribution of immune cell populations. Furthermore, we meticulously isolated MDSCs from the bone marrow of T1DM mice, probing into the expressions of genes pertaining to the advanced glycation end product receptor (RAGE)/NF-κB signaling pathway through RT-qPCR. Evidently, TCS exhibited a substantial capacity to effectively counteract the T1DM-induced elevation in random blood glucose, glycosylated hemoglobin, and IL-6 levels in plasma. Pathological scrutiny underscored the ability of TCS to mitigate the damage incurred by islets. Intriguingly, TCS interventions engendered a reduction in the proportion of MDSCs within the bone marrow, particularly within the IL-6+ MDSC subset. In contrast, IL-10+ MDSCs exhibited an elevation following TCS treatment. Moreover, we observed a significant down-regulation of relative mRNA of pro-inflammatory genes, including arginase 1 (Arg1), inducible nitric oxide synthase (iNOS), RAGE and NF-κB, within MDSCs due to the influence of TCS. It decreases total MDSCs and regulates the balance between IL-6+ and IL-10+ MDSCs thus alleviating the symptoms of T1DM. TCS also down-regulates the RAGE/NF-κB signaling pathway, making it a promising alternative therapeutic treatment for T1DM. Collectively, our study offered novel insights into the underlying mechanism by which TCS serves as a promising therapeutic intervention for T1DM.http://www.sciencedirect.com/science/article/pii/S2405844023101150Tian hua fenTrichosanthin(TCS)Type 1 diabetes mellitusMyeloid-derived suppressor cellsAdvanced glycation end product receptor |
spellingShingle | Jie Shu Kefan Wang Yuting Liu Jie Zhang Xuping Ding Hanxiao Sun Jiaoxiang Wu Biao Huang Ju Qiu Huiming Sheng Liming Lu Trichosanthin alleviates streptozotocin-induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow-derived IL6+ and IL10+ MDSCs Heliyon Tian hua fen Trichosanthin(TCS) Type 1 diabetes mellitus Myeloid-derived suppressor cells Advanced glycation end product receptor |
title | Trichosanthin alleviates streptozotocin-induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow-derived IL6+ and IL10+ MDSCs |
title_full | Trichosanthin alleviates streptozotocin-induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow-derived IL6+ and IL10+ MDSCs |
title_fullStr | Trichosanthin alleviates streptozotocin-induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow-derived IL6+ and IL10+ MDSCs |
title_full_unstemmed | Trichosanthin alleviates streptozotocin-induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow-derived IL6+ and IL10+ MDSCs |
title_short | Trichosanthin alleviates streptozotocin-induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow-derived IL6+ and IL10+ MDSCs |
title_sort | trichosanthin alleviates streptozotocin induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow derived il6 and il10 mdscs |
topic | Tian hua fen Trichosanthin(TCS) Type 1 diabetes mellitus Myeloid-derived suppressor cells Advanced glycation end product receptor |
url | http://www.sciencedirect.com/science/article/pii/S2405844023101150 |
work_keys_str_mv | AT jieshu trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT kefanwang trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT yutingliu trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT jiezhang trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT xupingding trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT hanxiaosun trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT jiaoxiangwu trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT biaohuang trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT juqiu trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT huimingsheng trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs AT liminglu trichosanthinalleviatesstreptozotocininducedtype1diabetesmellitusinmicebyregulatingthebalancebetweenbonemarrowderivedil6andil10mdscs |